Zimmer profits fall, but beat expectations

Back to TopCommentsE-mailPrintBookmark and Share

Profits fell at Zimmer Holdings Inc. during the third quarter, the company announced Thursday morning, but the maker of orthopedic implants exceeded the expectations of Wall Street analysts.

The Warsaw-based company recorded third-quarter profits of $150 million, down 30 percent from the same period a year ago. But, excluding extraordinary gains and charges from both quarters, Zimmer’s profit decline was a more modest 14 percent.

On that adjusted basis, Zimmer’s earnings totaled 88 cents per share, exceeding the predictions of Wall Street analysts who expected profits of 86 cents per share, according to data from Thomson Financial Network.

A year ago, Zimmer earned 97 cents per share in the third quarter.

“We believe we are stabilizing our core knee and hip franchises and establishing a solid foundation for future growth,” said Zimmer CEO David Dvorak in a statement.

Zimmer reaffirmed its full-year profit forecast, adjusted for extraordinary items. It called for a range of $3.85 to $4 per diluted share.

Sales in the third quarter rose 2.4 percent, to $976 million, turning around several quarters of declining revenue. Sales in the second quarter fell 5.5 percent, to $1.02 billion, or 0.6 percent when excluding currency fluctuations.

Zimmer’s stock price plunged during last fall’s sell-off on Wall Street. However, shares are up 29 percent in 2009. The company’s stock closed Wednesday at $52.23 per share.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ